newsfilter
← Latest News
GlobeNewswire·

NeuBase Announces Formation of Gene Editing Advisory Board

PITTSBURGH, May 16, 2023 (GLOBE NEWSWIRE) -- NeuBase Therapeutics, Inc. (NASDAQ:NBSE) ("NeuBase" or the "Company"), a biotechnology company developing Stealth Editors™ to perform in vivo gene editing without